202 related articles for article (PubMed ID: 6249957)
1. [Influence of vitamin D therapy on renal osteodystrophy in children (author's transl)].
Bulla M; Stock GJ; Delling G; Hofmann H; Offermann G
Klin Wochenschr; 1980 Mar; 58(5):237-47. PubMed ID: 6249957
[TBL] [Abstract][Full Text] [Related]
2. [Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].
Bulla M; Delling G; Benz-Bohm G; Stock GJ; Sánchez de Reutter A; Ziegler R; Lühmann H; Severin M; Kalbitzer E; Manegold C
Klin Wochenschr; 1980 May; 58(10):511-9. PubMed ID: 7392529
[TBL] [Abstract][Full Text] [Related]
3. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
[TBL] [Abstract][Full Text] [Related]
4. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy].
Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M
Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. The radiographic spectrum of renal osteodystrophy.
Molpus WM; Pritchard RS; Walker CW; Fitzrandolph RL
Am Fam Physician; 1991 Jan; 43(1):151-8. PubMed ID: 1986484
[TBL] [Abstract][Full Text] [Related]
7. Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol.
Bulla M; Delling G; Offermann G; Ziegler R; Benz G; Lühmann H; Sanchez de Reutter A; Severin M
Proc Eur Dial Transplant Assoc; 1979; 16():644-8. PubMed ID: 232917
[TBL] [Abstract][Full Text] [Related]
8. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide.
Verberckmoes R; Bouillon R; Krempien B
Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767
[TBL] [Abstract][Full Text] [Related]
9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
10. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
[TBL] [Abstract][Full Text] [Related]
11. Role of phosphate depletion and high dialysate calcium in controlling dialytic renal osteodystrophy.
Goldsmith RS; Johnson WJ
Kidney Int; 1973 Aug; 4(2):154-60. PubMed ID: 4744973
[No Abstract] [Full Text] [Related]
12. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
[TBL] [Abstract][Full Text] [Related]
13. Effect of calcitonin on hemodialysis patients with hypercalcemia and renal osteodystrophy.
Carney SL; Epstein MT
Uremia Invest; 1984-1985; 8(2):97-101. PubMed ID: 6537690
[TBL] [Abstract][Full Text] [Related]
14. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW
Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961
[TBL] [Abstract][Full Text] [Related]
15. Renal osteodystrophy.
Beale MG; Salcedo JR; Ellis D; Rao DD
Pediatr Clin North Am; 1976 Nov; 23(4):873-84. PubMed ID: 186748
[No Abstract] [Full Text] [Related]
16. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
Offermann G; Schaefer K; Schulz A; Delling G
Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
[TBL] [Abstract][Full Text] [Related]
17. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients.
Dogan E; Erkoc R; Sayarlioglu H; Soyoral Y; Dulger H
Ren Fail; 2008; 30(4):407-10. PubMed ID: 18569914
[TBL] [Abstract][Full Text] [Related]
18. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
Morio K; Koide K
Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
[TBL] [Abstract][Full Text] [Related]
19. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
Ziółkowska H; Pańczyk-Tomaszewska M; Majkowska Z; Rajkowski T; Debiński A; Przedlacki J; Sawicki A; Ostrowski K; Marciński A; Roszkowska-Blaim M
Med Sci Monit; 2001; 7(5):1034-42. PubMed ID: 11535955
[TBL] [Abstract][Full Text] [Related]
20. Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure.
Witmer G; Margolis A; Fontaine O; Fritsch J; Lenoir G; Broyer M; Balsan S
Kidney Int; 1976 Nov; 10(5):395-408. PubMed ID: 794558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
